International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) S1: Proposed Change to Rodent Carcinogenicity Testing of Pharmaceuticals - Regulatory Notice for Public Input

This notice was released by the ICH Steering Committee for consultation and is being posted on the Health Canada website for information and comment.

How to Get Involved

This consultation is open for comment starting February 5, 2013 until May 5, 2013. Please select and read through the link below titled "consultation document". Once read, please submit your comments via email, fax or by mail to:

Celia Lourenco, PhD
Interim Director
Office of Clinical Trials
Therapeutic Products Directorate
5th Floor, room 5071, Holland Cross, Tower B
1600 Scott Street, Ottawa, Ontario
K1A 0K9

Telephone: 613-954-6494
Fax: 613-952-9656
email: Celia.Lourenco@hc-sc.gc.ca

Consultation Document

Interested parties are encouraged to provide comments and suggestions by May 5, 2013.

Reporting to Canadians

Health Canada will make the results of this consultation available on this Web site.

If you have any questions, contact Celia Lourenco.